Bresch testifies to Oversight committee, defends EpiPen's price

Mylan CEO Heather Bresch fielded questions on the cost of EpiPen, her own compensation, her mother's involvement in getting the auto-injectors in schools nationwide, and the company's profits during a hearing Wednesday before the U.S. House Committee on Oversight and Government Reform.